Does BIO-RSA Provides Superior Clinical Outcome Compared to Conventional RSA?
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45-80
SponsorLovisenberg Diakonale Hospital
About this trial
The goal of this clinical trial is to compare two different types of reverse shoulder replacements. Researchers will compare a conventional reverse shoulder replacement with a lateralized reverse shoulder replacement to see if there is a difference in how well the patients function after two years.
Eligibility criteria
Qualifiers
Eligible for primary RSA due to OA, massive RC tear, failed RC repair or post-instability osteoarthritis
Able to read or write Norwegian
Disqualifiers
Severe osteoporosis
Osteonecrosis of the humeral head
Dementia
Poor deltoid function
Trial design
Treatments tested in this trial
- BIO-RSA
- RSA
Treatment groups
130 Participants
are divided into 2 treatment groupsSponsors and collaborators
Lovisenberg Diakonale Hospital
Lead sponsor
Haukeland University Hospital
Collaborator
Sykehuset Telemark
Collaborator
University Hospital, Akershus
Collaborator
Source ClinicalTrials.gov